Latest news on Psychiatry and Addictions

Check back here regularly to find out what's going on at 

Wayne Dyer Top 10...

Number 4 is my favouite

"Have a mind that is open to everything...and attached to nothing"

Dr Jas Grewal, Consultant Psychiatrist

The Default Mode Network

Mind wandering is particularly common in neurotisicm and addiction- a restless, wandering mind is associated with unhappiness and difficulty sleeping

Dr Jas Grewal, Consultant Psychiatrist

The Restless Mind

Many of my patients complain of being tired all day- but are 'wide awake' at 11pm when it's time to sleep...

Dr Jas Grewal, Consultant Psychiatrist

What is 'Monkey Mind'

I’m sure we can all relate to this. You lay down in bed wanting to relax / sleep but you mind is so busy you can’t stop thinking about a hundred things at the same time. An hour passes by and you still can’t sleep. Living in a busy world has its toll on our mental state. This toll is what the Monk’s call “The monkey mind”. 

Dr Jas Grewal, Consultant Psychiatrist

Search Inside Yourself: Chad-Meng Tan

Search Inside Yourself reveals how to calm your mind on demand and return it to a natural state of happiness, deepen self-awareness in a way that fosters self-confidence, harness empathy and compassion into outstanding leadership, and build highly productive collaborations based on trust and transparent communication. In other words, Search Inside Yourself shows you how to grow inner joy while succeeding at your work.

Dr Jas Grewal, Consultant Psychiatrist

The Habits of Happiness

A great 20min lecture by Buddhist monk and neuroscientist Matthieu Ricard

Dr Jas Grewal, Consultant Psychiatrist

Mindfulness lecture

This is a great introduction to mindfulness by Dr Kabatt-Zinn

Dr Jas Grewal, Consultant Psychiatrist


Now approved by NICE

The first drug to help dependent drinkers cut down on their alcohol use has been approved by NICE.

Nalmefene has been approved for treating patients with alcohol dependence without physical withdrawal symptoms and who do not need immediate detoxification.

The manufacturer, Lundbeck, estimate that around 600,000 drinkers in England could be eligible for treatment with the drug - an opioid receptor antagonist - which dampens the ‘buzz’ alcohol-dependent people get from drinking, helping them cut down their alcohol intake.

Patients suitable for treatment with the drug regularly drink more than the World Health Organisation-defined ‘high drinking risk’ levels of seven-and-a-half units of alcohol per day for men, and five units per day for women.

And NICE draft guidance advises that nalmefene should only be started on patients who continue to have this high drinking risk level two weeks after their initial assessment.

The approval comes after trials have shown that the drug, when used in conjunction with counselling, has cut alcohol consumption by an average of 61 per cent after six months, according to its manufacturers.

The drug was approved by the Scottish Medicines Consortium in October last yearwhen NICE said it was looking at whether to introduce it here.

The NHS cost for nalmefene is £42.42 for 14 tablets, with the maximum daily dose one tablet. Patients take a tablet when they feel they are at risk of drinking, preferably an hour or two before they anticipate they might drink alcohol.

NICE is expected to publish its final guidance for nalmefene in November.